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The merger between the world’s two largest
beer producers—AB InBev and SABMiller—
has potentially far-reaching consequences for
health in Africa. The deal, announced in
November 2015 and agreed by the European
Commission on 24th May, will result in this
new conglomerate having a dominant pos-
ition in the global beer market.1
The merger comes at a key juncture for
the global alcohol industry. Alcohol-related
health harms have been gaining critical
attention in many high-income countries,2
leading to revisions to guidance on alcohol
consumption3 in some cases (eg, in the UK4)
and moves towards greater regulation of the
sale and marketing of alcoholic beverages,
such as the proposed introduction of
minimum pricing for alcohol in Scotland.5
With reductions in consumption observed in
more mature markets,6 the alcohol industry
is under increasing pressure to open up and
develop new sources of growth and proﬁt
elsewhere. Confronted with this more difﬁ-
cult business environment in their home
markets, the global alcohol industry is
increasingly looking to populous, less regu-
lated but ever more afﬂuent low and middle
income countries (LMICs) as a source of
new consumers.7
An emerging body of evidence demon-
strates that expansion into Africa is an expli-
cit part of the industry’s growth strategy1 7 8
and that companies are already lobbying gov-
ernments and shaping policy environments
to facilitate this growth.7 The distinguishing
feature of alcohol drinking in Africa is the
combination of high rates of abstention and
high-intensity consumption among those
who do drink.9 The alcohol industry itself
reports that rising beer consumption across
the African continent is resulting in an
increased total per capita consumption of
alcohol.8
The merger with SABMiller, with its exten-
sive African distribution networks, offers AB
InBev the ideal platform from which to
market its global brands throughout the con-
tinent. This has a number of implications for
alcohol consumption and harms across the
continent.
Evidence of the health impact of alcohol
in LMICs is already emerging,10 with alcohol
consumption a leading risk factor in
Southern Africa in the Global Burden of
Disease Study. In addition to its role as a risk
factor for non-communicable diseases such
as liver cirrhosis, heart disease and a range of
common cancers (including cancers of the
breast, throat and mouth), alcohol interacts
with other health challenges such as HIV9 11
road trafﬁc accidents,12 violence, including
domestic violence, and mental poor health.13
The increasing focus of the global alcohol
industry on LMICs mirrors the move by big
tobacco into emerging economies in preced-
ing decades.14 Evidence from the tobacco
sector underlines precisely why this merger,
and the shift in strategy which it represents,
is bad news for health in Africa in particular.
The entry of transnational tobacco corpora-
tions into new markets led to increases in
consumption, and evidence suggests that
market entry by the global alcohol industry
has similar effects.15 Market entrance and
consolidation by transnational corporations
is often facilitated by predatory pricing
(setting such a low price that competitors are
driven out of the market) to undercut
domestic producers, allied with sophisticated
branding and marketing strategies to drive
consumption. One such strategy is shaping
the public’s understanding of ‘responsible’
and/or ‘moderate’ drinking via their own
corporate social responsibility (CSR) cam-
paigns,16 such as AB InBev ‘Global Smart
Drinking Goals’ goals, one of which speciﬁc-
ally aimed at beer consumption (“Ensure no-
or lower-alcohol beer products represent at
least 20% of AB InBev’s global beer volume
by the end of 2025”).17 Although this may
appear like a positive message, research on
similar strategies indicates that this is unlikely
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to be about substituting regular beer products for lower,
but rather increasing the overall size of the beer market
through an expanded range of products.18 It also
deﬂects responsibility from the industry to the individual
drinker, while encouraging them to make their own
minds up as to what constitutes ‘moderation’.
Sub-Saharan Africa provides particularly fertile ground
for this business model. Low advertising cost, weak regu-
lation, high-intensity consumption of beer in these
markets7 and, once the merger is completed, very
limited competition are the ideal environment for mar-
keting global brands. Alcohol companies have developed
low-cost, ‘entry-level’ products aimed at attracting new
consumers, citing the greater safety of commercially pro-
duced products over ‘homebrew’. An example of this is
the introduction of commercially manufactured
‘Chibuku Shake Shake’ beer by SABMiller in Zambia,
which is based on a locally brewed traditional sorghum
beer but is marketed as offering more consistent quality
than the homebrew variant.19 Moreover, the drinks
industry are pushing alcohol prices down by encour-
aging governments to restructure their tax regimes in
order to crowd out this informal market.7 The promo-
tion of their products as safer alternatives forms part of
a wider CSR agenda. CSR activities such as contributing
to water sanitation projects, for example Diageo’s Water
Blueprint,20 aim to highlight their positive social impact.
CSR and government partnerships are likely to be a
further avenue through which the industry will seek to
inﬂuence and limit regulation and formulate policy
agendas.21 For example, national alcohol policy docu-
ments from four sub-Saharan countries have been found
to be identical and reﬂecting the alcohol industry’s pre-
ferred policy wording.8
The political economy of alcohol in Sub-Saharan
Africa is only partially documented and remains poorly
understood.22 The concentration of ownership (illu-
strated by the merger of AB InBev and SABMiller)
confers market dominance which allows the industry to
drive a strategy of low price, as well as offering the
advantage of inﬂuencing regional alcohol policy in ways
that are harmful to public health.23 As the global
alcohol industry moves to expand into the continent,
much greater research, policy and public attention
needs to be paid to industry practices and governance
mechanisms to help understand and prevent negative
impacts on the population’s health.
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